Skip to content

Spot Depression Study

A Blood Test to Identify Persons at Risk of Developing Depression or Bipolar Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02804867
Enrollment
1000
Registered
2016-06-17
Start date
2016-03-31
Completion date
2016-09-30
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Depressive Disorder

Brief summary

This study aims to identify signs of depression and bipolar disorder by measuring changes of certain molecules (biomarkers) that can be detected in dried blood spots. Our goal is to use these biomarkers to develop a diagnostic test to enable early treatment, which can lead to better patient outcomes.

Detailed description

Bipolar disorder and major depression are serious mental health conditions that have a devastating impact on patients, their families and friends, and society. Currently, no laboratory test exists for these disorders. We are trying to develop a molecular test based on blood spots (small spots of blood obtained from patients' fingertips that have been dried on special paper). Volunteers take part by filling out the questionnaire at www.spot-depression.org. They may then be selected to provide a dried blood spot, which can be collected at home using a kit that will be mailed to their address.

Interventions

PROCEDUREOnline questionnaire and self-administered blood spot

Sponsors

University of Cambridge
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Residing in the United Kingdom * Over 18 years of age

Exclusion criteria

* Pregnant or breastfeeding * Presence of blood-borne infection

Design outcomes

Primary

MeasureTime frame
Comparison of protein concentrations in dried blood spots between patient groups and controlsBaseline (at enrollment); no follow-up
Assessment of classification accuracy of protein concentrations in dried blood spots for distinguishing between bipolar disorder and depressionBaseline (at enrollment); no follow-up

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026